source
- Scribe records upsized $129M IPO to bankroll lipid-lowering genetic medsIn vivo gene editing outfit Scribe Therapeutics has priced its IPO at $128.7 million, surpassing the $96 million goal set out earlier this week.Fierce Biotech · 5d ago↗ source
- STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptidesThe panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.STAT · 5d ago↗ source
- U.S. health officials are investigating a new outbreak of a diarrhea-causing parasiteFederal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora.STAT · 5d ago↗ source